Aetna's Profit Rises on Gains
Aetna's first-quarter earnings rose 29% on gains from investments and the reversal of prior reserves, but membership fell. online.wsj.com |
Panel Wants to Change How We Eat
A federal nutrition panel is charged with coming up with recommendations that will figure in the government's planned update of the iconic food pyramid. online.wsj.com |
Six Trades on FDA, Clinical Trial Binary Events
Mike Havrilla submits:Below are some Regulatory Catalyst Index updates for companies with recent FDA and clinical trial related news... BioSante Pharma (NASDAQ:BPAX)Complete Story » seekingalpha.com |
New Data Supports Valdoxan - Video
New Data Supports Valdoxan’s® Unique Clinical Signature feedproxy.google.com |
Astra's Cancer Drug Fails Trial
AstraZeneca suffered a fresh setback with news its experimental prostate-cancer pill Zibotentan failed in a late clinical trial to significantly improve overall survival. online.wsj.com |